Abstract
Studies describing the effects of leukemia inhibitory factor (LIF) on adipocyte differentiation in murine cells have shown varying results. For example, LIF has been reported to have a suppressive effect on adipocyte differentiation in the 3T3-L1 cell line, whereas it promoted adipocyte differentiation in the Ob1771 and 3T3-F442A cell lines. Thus, it is possible that the effects of LIF on adipogenesis vary with the developmental stage of the cells or tissues, but the details remain unclear. To further elucidate the role of LIF in adipogenesis, we investigated the effects of LIF on murine bone marrow stromal cells at the early and late stages of adipogenesis. LIF decreased the number of lipid foci and suppressed the expression levels of adipocyte differentiation markers at day 5; however, it enhanced these same traits at day 15. A previous report showed that the expression levels of Wnt signaling molecules are different at the early and late differentiation stages; therefore, we investigated the relationship between LIF and Wnt signaling. LIF affected the mRNA expression levels of different Wnt signaling molecules but inhibited the expression level of β-catenin protein at both days 5 and 15. Our data suggest that LIF has reciprocal roles during the early and late stages of adipocyte differentiation, regulating the Wnt signaling pathway.
Similar content being viewed by others
References
Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276, 71–74.
Friedenstein, A. J., Gorskaja, J. F., & Kulagina, N. N. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology, 4, 267–274.
Owen, M. (1988). Marrow stromal stem cells. Journal of Cell Science Supplement, 10, 63–76.
Itoh, S., & Aubin, J. E. (2009). A novel purification method for multipotential skeletal stem cells. Journal of Cellular Biochemistry, 108, 368–377.
Caplan, A. I. (1991). Mesenchymal stem cells. Journal of Orthopaedic Research, 9, 641–650.
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143–147.
Tang, Q. Q., & Lane, M. D. (2012). Adipogenesis: From stem cell to adipocyte. Annual Review of Biochemistry, 81, 715–736.
MacDougald, O. A., & Lane, M. D. (1995). Transcriptional regulation of gene expression during adipocyte differentiation. Annual Review of Biochemistry, 64, 345–373.
Mandrup, S., & Lane, M. D. (1997). Regulating adipogenesis. Journal of Biological Chemistry, 272, 5367–5370.
Otto, T. C., & Lane, M. D. (2005). Adipose development: From stem cell to adipocyte. Critical Reviews in Biochemistry and Molecular Biology, 40, 229–242.
Muruganandan, S., Roman, A. A., & Sinal, C. J. (2009). Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cellular and Molecular Life Sciences, 66, 236–253.
Hong, J. H., & Yaffe, M. B. (2006). TAZ: A beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle, 5, 176–179.
Ross, S. E., Hemati, N., Longo, K. A., Bennett, C. N., Lucas, P. C., Erickson, R. L., & MacDougald, O. A. (2000). Inhibition of adipogenesis by Wnt signaling. Science, 289, 950–953.
Kang, S., Bennett, C. N., Gerin, I., Rapp, L. A., Hankenson, K. D., & Macdougald, O. A. (2007). Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. Journal of Biological Chemistry, 282, 14515–14524.
Christodoulides, C., Lagathu, C., Sethi, J. K., & Vidal-Puig, A. (2009). Adipogenesis and WNT signalling. Trends in Endocrinology and Metabolism, 20, 16–24.
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005). Regulation of osteoblastogenesis and bone mass by Wnt10b. Proceedings of the National Academy of Sciences of the USA, 102, 3324–3329.
Moldes, M., Zuo, Y., Morrison, R. F., Silva, D., Park, B. H., Liu, J., & Farmer, S. R. (2003). Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochemical Journal, 376, 607–613.
Qiu, W., Andersen, T. E., Bollerslev, J., Mandrup, S., Abdallah, B. M., & Kassem, M. (2007). Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. Journal of Bone and Mineral Research, 22, 1720–1731.
Rawadi, G., Vayssiere, B., Dunn, F., Baron, R., & Roman-Roman, S. (2003). BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. Journal of Bone and Mineral Research, 18, 1842–1853.
Boland, G. M., Perkins, G., Hall, D. J., & Tuan, R. S. (2004). Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. Journal of Cellular Biochemistry, 93, 1210–1230.
Cho, H. H., Kim, Y. J., Kim, S. J., Kim, J. H., Bae, Y. C., Ba, B., & Jung, J. S. (2006). Endogenous Wnt signaling promotes proliferation and suppresses osteogenic differentiation in human adipose derived stromal cells. Tissue Engineering, 12, 111–121.
Bowers, R. R., & Lane, M. D. (2008). Wnt signaling and adipocyte lineage commitment. Cell Cycle, 7, 1191–1196.
Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E, Jr, & Yancopoulos, G. D. (1995). Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science, 267, 1349–1353.
Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., et al. (1994). Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science, 263, 92–95.
White, U. A., & Stephens, J. M. (2011). The gp130 receptor cytokine family: Regulators of adipocyte development and function. Current Pharmaceutical Design, 17, 340–346.
Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G., & Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochemical Journal, 374, 1–20.
Kimber, S. J. (2005). Leukaemia inhibitory factor in implantation and uterine biology. Reproduction, 130, 131–145.
Alonzi, T., Middleton, G., Wyatt, S., Buchman, V., Betz, U. A., Muller, W., et al. (2001). Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Molecular and Cellular Neuroscience, 18, 270–282.
Itoh, S., Udagawa, N., Takahashi, N., Yoshitake, F., Narita, H., Ebisu, S., & Ishihara, K. (2006). A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone, 39, 505–512.
Yoshitake, F., Itoh, S., Narita, H., Ishihara, K., & Ebisu, S. (2008). Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. Journal of Biological Chemistry, 283, 11535–11540.
Williams, R. L., Hilton, D. J., Pease, S., Willson, T. A., Stewart, C. L., Gearing, D. P., et al. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature, 336, 684–687.
Falconi, D., Oizumi, K., & Aubin, J. E. (2007). Leukemia inhibitory factor influences the fate choice of mesenchymal progenitor cells. Stem Cells, 25, 305–312.
Nuttall, M. E., & Gimble, J. M. (2004). Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Current Opinion in Pharmacology, 4, 290–294.
Beresford, J. N., Bennett, J. H., Devlin, C., Leboy, P. S., & Owen, M. E. (1992). Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. Journal of Cell Science, 102(Pt 2), 341–351.
Aubert, J., Dessolin, S., Belmonte, N., Li, M., McKenzie, F. R., Staccini, L., et al. (1999). Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. Journal of Biological Chemistry, 274, 24965–24972.
Mori, M., Yamaguchi, K., & Abe, K. (1989). Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun, 160, 1085–1092.
Greenberg, A. S., Nordan, R. P., McIntosh, J., Calvo, J. C., Scow, R. O., & Jablons, D. (1992). Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: A possible role for interleukin 6 in cancer cachexia. Cancer Research, 52, 4113–4116.
Bennett, C. N., Ross, S. E., Longo, K. A., Bajnok, L., Hemati, N., Johnson, K. W., et al. (2002). Regulation of Wnt signaling during adipogenesis. Journal of Biological Chemistry, 277, 30998–31004.
Longo, K. A., Wright, W. S., Kang, S., Gerin, I., Chiang, S. H., Lucas, P. C., et al. (2004). Wnt10b inhibits development of white and brown adipose tissues. Journal of Biological Chemistry, 279, 35503–35509.
Acknowledgments
The authors thank the members of the Aubin lab for discussion. This work was supported by Grants-in-Aid for Scientific Research (24689070 and 25670809) from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Additional information
Shun Ikeda and Shousaku Itoh have contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ikeda, S., Itoh, S., Yamamoto, Y. et al. Developmental Stage-Dependent Effects of Leukemia Inhibitory Factor on Adipocyte Differentiation of Murine Bone Marrow Stromal Cells. Cell Biochem Biophys 74, 11–17 (2016). https://doi.org/10.1007/s12013-015-0703-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-015-0703-8